Active Smoking May Negatively Affect Response Rate, Progression-Free Survival, and Overall Survival of Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib-Reference-Cited by-同舟云学术

Active Smoking May Negatively Affect Response Rate, Progression-Free Survival, and Overall Survival of Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib

Published:2013-12-05 Issue:1 Volume:19 Page:51-60
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:

Author:

Keizman Daniel¹,Gottfried Maya¹,Ish-Shalom Maya¹,Maimon Natalie¹,Peer Avivit²,Neumann Avivit²,Hammers Hans³,Eisenberger Mario A.³,Sinibaldi Victoria³,Pili Roberto⁴,Hayat Henry⁵,Kovel Svetlana⁶,Sella Avishay⁶,Boursi Ben⁷,Weitzen Rony⁷,Mermershtain Wilmosh⁸,Rouvinov Keren⁸,Berger Raanan⁷,Carducci Michael A.³

Affiliation:

1. Genitourinary Oncology Service, Institute of Oncology, Meir Medical Center and the Sackler School of Medicine, Tel Aviv University, Kfar-Saba, Israel;

2. Department of Oncology, Rambam Medical Center, Haifa, Israel;

3. Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA;

4. Roswell Park Cancer Institute, Buffalo, New York, USA;

5. Department of Oncology, Wolfson Medical Center, Holon, Israel;

6. Department of Oncology, Asaf Harofe Medical Center, Zerifin, Israel;

7. Department of Oncology, Sheba Medical Center, Tel Hashomer, Israel;

8. Department of Oncology, Soroka University Medical Center, Beer-sheva, Israel

Abstract

Learning Objectives Describe the association between risk factors for renal cell carcinoma and the outcome of sunitinib treatment for metastatic disease. Explain the impact of active smoking on the outcome of sunitinib-treated metastatic renal cell carcinoma. Discuss obesity, hypertension, and diabetes in relation to the outcome of sunitinib-treated metastatic renal cell carcinoma.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://pericles-gcp.literatumonline.com/doi/pdf/10.1634/theoncologist.2012-0335

Reference32 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

2. Novel approaches in the therapy of metastatic renal cell carcinoma;Lam;World J Urol,2005

3. Renal-cell carcinoma;Motzer;N Engl J Med,1996

4. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease;Janzen;Urol Clin North Am,2003

5. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma;Motzer;N Engl J Med,2007

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted nanomedicine modulating intercellular communications to arrest renal cell carcinoma progression;Journal of Drug Delivery Science and Technology;2024-09

2. Evaluating the Prognostic Variables for Overall Survival in Patients with Metastatic Renal Cell Carcinoma: A Meta-Analysis Of 29,366 Patients;JU Open Plus;2024-04

3. The significance of preoperative neutrophil-to-lymphocyte ratio in predicting short-term complications and survival benefits of pancreaticoduodenectomy: A systematic review and meta-analysis;The American Journal of Surgery;2023-11

4. Impact of BMI on the Survival of Renal Cell Carcinoma Patients Treated with Targeted Therapy: A Systematic Review and Meta-Analysis;Nutrition and Cancer;2023-07-18

5. Smoking Cessation After Diagnosis of Kidney Cancer Is Associated With Reduced Risk of Mortality and Cancer Progression: A Prospective Cohort Study;Journal of Clinical Oncology;2023-05-20